Solara Active Pharma Sciences scheduled a conference call for May 15, 2026, to discuss its audited Q4 and FY26 financial results.
The group meet for analysts and investors will feature management including the Founder, MD & CEO, and CFO.
The company confirmed the call details and presentation materials will be available on its investor relations website.
No unpublished price sensitive information (UPSI) is expected to be shared during the scheduled engagement.